/ 
/ 
Pidotimod
From Wikipedia, the free encyclopedia
 |
|
|
Pidotimod
|
|
| Systematic (IUPAC) name | |
| (4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acid | |
| Identifiers | |
| CAS number | ? |
| ATC code | L03 |
| PubChem | |
| Chemical data | |
| Formula | C9H12N2O4S |
| Mol. mass | 244.26758 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Pidotimod is an immunostimulant.[1]
[edit] References
- ^ Du XF, Jiang CZ, Wu CF, Won EK, Choung SY (September 2008). "Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression". Archives of pharmacal research 31 (9): 1153–9. doi:. PMID 18806958, http://dx.doi.org/10.1007/s12272-001-1282-6.
|
|||||||||||||||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |